NCT05122234View on ClinicalTrials.gov

Mesenchymal Stem Cell Secretome In Severe Cases of COVID-19

PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 10, 2020

Primary Completion Date

July 30, 2021

Study Completion Date

November 14, 2021

Conditions
COVID-19
Interventions
BIOLOGICAL

Injection of secretome - mesenchymal stem cell

Secretome will be given once at a dose of 15 ml per administration dissolved in 100 ml of normal saline. The administration is done intravenously for 60 minutes.

OTHER

Placebo

Normal saline

DRUG

Standard treatment of Covid-19

Standard treatment of Covid-19 based on national protocol.

Trial Locations (4)

Unknown

RSUP Fatmawati, Jakarta

RSUP Persahabatan, Jakarta

RSUPN Dr. Cipto Mangunkusumo, Jakarta Pusat

Rumah Sakit Universitas Indonesia, Depok

All Listed Sponsors
lead

Indonesia University

OTHER

NCT05122234 - Mesenchymal Stem Cell Secretome In Severe Cases of COVID-19 | Biotech Hunter | Biotech Hunter